Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000239363 | SCV000297692 | likely benign | Mitochondrial complex II deficiency, nuclear type 1; Paragangliomas 5 | 2024-01-30 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000568221 | SCV000674927 | likely benign | Hereditary cancer-predisposing syndrome | 2016-03-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Sema4, |
RCV000568221 | SCV002527774 | benign | Hereditary cancer-predisposing syndrome | 2021-12-23 | criteria provided, single submitter | curation | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV002479953 | SCV002773966 | benign | not specified | 2021-07-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003967682 | SCV004777552 | likely benign | SDHA-related condition | 2023-01-05 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |